Latest publications
Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity.
- Tumor Immunotherapy and Microenvironment
2017 Jan. OncoImmunology.6(2):e1271858.
Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy.
- Tumor Immunotherapy and Microenvironment
2016 Dec. Oncologist.21(12):1416-e17. Epub 2016 Nov 30.
Hijacker of the antitumor immune response: autophagy is showing its worst facet.
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
2016 Nov. Front Oncol.6(246):246.
Mesenchymal stromal cells can regulate the immune response in the tumor microenvironment.
- Tumor Immunotherapy and Microenvironment
2016 Nov. Vaccines.4(4).
Renal cell carcinoma programmed death-ligand 1, a new direct target of hypoxia-inducible factor-2 alpha, is regulated by von Hippel-Lindau gene mutation status.
- Tumor Immunotherapy and Microenvironment
2016 Oct. Eur Urol.70(4):623-632. Epub 2015 Dec 23.
miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function.
- Tumor Immunotherapy and Microenvironment
2016 Sep. Cancer Lett.380(1):257-62. Epub 2015 Oct 30.
Role of autophagy in tumor progression and regression. In Targeting autophagy in cancer therapy. (Book Chapter)
- Tumor Immunotherapy and Microenvironment
2016 Sep. Yang J-M, ed. Springer International Publishing, 2016. p.117-131. (Current Cancer Research). ISBN 978-3-319-42740-9.
The multifaceted role of autophagy in tumor evasion from immune surveillance.
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
2016 Apr. Oncotarget.7(14):17591-607.
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-beta and miR23a transfer.
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
2016 Apr. OncoImmunology.5(4):e1062968. Epub 2015 Jun 24.
Prospective evaluation of first-Line erlotinib in advanced Non-Small Cell Lung Cancer (NSCLC) carrying an activating EGFR mutation: A multicenter academic phase II study in Caucasian patients (FIELT).
- Tumor Immunotherapy and Microenvironment
2016 Mar. PLoS One.11(3):e0147599.
Autophagy Activation in the Tumor Microenvironment: A Major Process in Shaping the Antitumor Immune Response. In Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging. 1st ed. (Book Chapter)
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
2016 Feb. San Diego: Academic Press, 2016. p.267-290. (Vol. 8). ISBN 978-0-12-802937-4.
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
- Proteomics of Cellular Signaling
- Tumor Immunotherapy and Microenvironment
2016 Jan. Autophagy.12(1):1-222.
Autophagy regulation of the tumor immunity: An old housekeeper for a new function. In Cell Death - Autophagy, Necrosis and Apoptosis. (Book Chapter)
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
2015 Dec. Ntuli DT, ed. Rijeka: InTech, 2015. p.37-61. ISBN 978-953-51-2236-4.
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
- Tumor Immunotherapy and Microenvironment
2015 Nov. Am J Physiol Cell Physiol.309(9):C569-79. Epub 2015 Aug 26.
miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells.
- Tumor Immunotherapy and Microenvironment
2015 Oct. OncoImmunology.4(12):e996475.
The selective degradation of synaptic connexin 43 protein by hypoxia-induced autophagy impairs natural killer cell-mediated tumor cell killing.
- Tumor Immunotherapy and Microenvironment
2015 Sep. J Biol Chem.290(39):23670-9. Epub 2015 Jul 28.
Tumor-promoting effects of myeloid derived suppressor cells are potentiated by hypoxia-induced expression of miR-210.
- Tumor Immunotherapy and Microenvironment
2015 Sep. Cancer Res.75(18):3771-87. Epub 2015 Jul 23.
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
- Tumor Stroma Interactions
- Tumor Immunotherapy and Microenvironment
- Integrated BioBank of Luxembourg
- Proteomics of Cellular Signaling
2015 Aug. Blood.126(9):1106-17. Epub 2015 Jun 22.
Screening protein isoforms predictive for cancer using immunoaffinity capture and fast LC-MS in PRM mode.
- Proteomics of Cellular Signaling
- Tumor Immunotherapy and Microenvironment
2015 Aug. Proteomics Clin Appl.9(7-8):695-705. Epub 2015 Mar 30.
Hypoxia: A Formidable Saboteur of the Anti-tumor Response. In Resistance of Cancer Cells to CTL-Mediated Immunotherapy. (Book Chapter)
- Tumor Immunotherapy and Microenvironment
2015 Jun. Bonavida B and Chouaib S, eds. Springer, 2015. p.115-142. (Series Resistance to Targeted Anti-Cancer Therapeutics, Vol. 7). ISBN 978-3-319-17806-6.